Direct healthcare provider Nomi Health recently closed a $110M Series A round to help advance the company’s mission of addressing care gaps, a huge sum for a company that got its start in 2019.
- Nomi currently serves 30k daily patients across 10 states, providing care for those that prefer not to go through traditional payor / provider channels.
- The company deploys mobile care units to locations such as universities and local businesses to deliver on-site services including vaccinations, COVID testing, and preventative screenings.
- The direct healthcare model allows Nomi to bypass many of the operational inefficiencies faced by larger incumbents, lowering overall expenses for recently added offerings such as COVID-19 vaccines and monoclonal antibody treatment.
- The latest funding will help Nomi deliver more services to “care deserts” such as rural areas and prisons, while also expanding its direct healthcare acquisition business.
The Takeaway
Nomi’s Series A makes it the 63rd company to raise over $100M this year, although the size of the round is more in line with a Series C for a company further along in its life cycle.
The funding total not only reflects the boiling hot state of broader digital health investment, but also the size of the market that Nomi has set its sights on.
Expect some acquisition news from Nomi in the near term – $110M is a large war chest, and when they’re done picking up vans, they’ll likely add some competitors to their Christmas list.
